Academic Journal

Re‐irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)

التفاصيل البيبلوغرافية
العنوان: Re‐irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)
المؤلفون: Stephanie E. Combs, Maximilian Niyazi, Sebastian Adeberg, Nina Bougatf, David Kaul, Daniel F. Fleischmann, Arne Gruen, Emmanouil Fokas, Claus M. Rödel, Franziska Eckert, Frank Paulsen, Oliver Oehlke, Anca‐Ligia Grosu, Annekatrin Seidlitz, Annika Lattermann, Mechthild Krause, Michael Baumann, Maja Guberina, Martin Stuschke, Volker Budach, Claus Belka, Jürgen Debus, Kerstin A. Kessel
المصدر: Cancer Medicine, Vol 7, Iss 5, Pp 1742-1749 (2018)
بيانات النشر: Wiley, 2018.
سنة النشر: 2018
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: Outcome, prognostic score, recurrent glioma, re‐irradiation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف: Abstract The heterogeneity of high‐grade glioma recurrences remains an ongoing challenge for the interdisciplinary neurooncology team. Response to re‐irradiation (re‐RT) is heterogeneous, and survival data depend on prognostic factors such as tumor volume, primary histology, age, the possibility of reresection, or time between primary diagnosis and initial RT and re‐RT. In the present pooled analysis, we gathered data from radiooncology centers of the DKTK Consortium and used it to validate the established prognostic score by Combs et al. and its modification by Kessel et al. Data consisted of a large independent, multicenter cohort of 565 high‐grade glioma patients treated with re‐RT from 1997 to 2016 and a median dose of 36 Gy. Primary RT was between 1986 and 2015 with a median dose of 60 Gy. Median age was 54 years; median follow‐up was 7.1 months. Median OS after re‐RT was 7.5, 9.5, and 13.8 months for WHO IV, III, and I/II gliomas, respectively. All six prognostic factors were tested for their significance on OS. Aside from the time from primary RT to re‐RT (P = 0.074) and the reresection status (P = 0.101), all factors (primary histology, age, KPS, and tumor volume) were significant. Both the original and new score showed a highly significant influence on survival with P
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2045-7634
Relation: https://doaj.org/toc/2045-7634
DOI: 10.1002/cam4.1425
URL الوصول: https://doaj.org/article/1371874117c14ba780f06fcf29c3de35
رقم الانضمام: edsdoj.1371874117c14ba780f06fcf29c3de35
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20457634
DOI:10.1002/cam4.1425